Online / Physical Event

World Summit on

Oncology & Oncologists

Theme: Oncologists meeting: To classify a responsive discourse on cancer science and treatment

Event Date & Time

Event Location

Brisbane, Australia

Brochure Program Abstract Registration ReaderBase Awards

20 Years Of Excellence in Scientific Events

441357340013

Performers / Professionals From Around The Globe

Conference Speaker

LIANE DELIGDISCH

The Mount Sinai Icahn School of Medicine
USA

Conference Speaker

FABIAN SCHNEIDER

Definiens AG, Germany
Germany

Conference Speaker

FRANCES MARY JOHNSON

Carl R. Darnell Army Medical Center
USA

Conference Speaker

WEN JIE ZHANG

Shihezi University School of Medicine, China
China

Conference Speaker

MARíA AH CHU DE SPENGLER

Panama University, Republic of Panama
Panama

Conference Speaker

ALVARO MACIEIRA-COELHO

French National Institute of Health (INSERM)
France

Conference Speaker

J C HAHNE

The Institute of Cancer Research, United Kingdom
UK

Conference Speaker

ERNESTINA M DE FRANCESCO

School of Environment and Life Sciences, University of Salford, UK
UK

Conference Speaker

SIGITA LIUTKAUSKIENE

Lithuanian University of Health Sciences, Lithuania
Lithuania

Conference Speaker

WASSIL NOWICKY

Ukrainian Anti-Cancer Institute
Austria

Conference Speaker

SIMSEK SELCUK FIKRI

Turkey Medical Faculty, Firat University
Turkey

Conference Speaker

ASLI GIRAY

Alanya Alaaddin Keykubat University, Turkey
Turkey

Tracks & Key Topics

Oncology 2021

ABOUT CONFERENCE

EuroSciCon Ltd takes immense delight & feels honored in inviting the participants across the globe to attend the Oncology & Cancer Science 2019 conference which is held during July 25-26, 2019 Philadelphia, USA. The main theme of our conference is " Oncologists meeting: To codify a responsive discussion on cancer science and therapy" with an objective to inspire young minds and their research abilities by providing an opportunity to meet the professionals in the field of Oncology. Oncology Conference 2019 is invented to explore various applications in Oncology.

What's New:

This Oncology Conference will have two days of discussions on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on Prevention, Diagnosis, and Treatment of the Organ-related Cancers and its innovative techniques. This Oncology Conference gives a chief interdisciplinary stage to experts, professionals, and teachers to display and discuss the latest developments in the fields of Oncology. It is crucial for oncologists to keep updated with the novel advancements in oncology and management of cancer. Oncology conference enhances the cancer research with the goal of increasing cure rates.

Conference Tracks:

  • Melanoma of the Head and Neck
  • Neuro-oncology
  • Breast Cancer
  • Tonsil Cancer
  • Molecular Biology of Head and Neck Cancers
  • Throat Cancer
  • Cancer Proteomics
  • Cancer Stem Cells
  • Types Of Cancers
  • Oncology and Radiology
  • Cancer Pharmacology
  • Nanotechnology in Cancer Treatment
  • Novel Approaches and pharmaceutical drugs for cancer Treatment
  • Nursing oncology
  • Organ-Defined Cancers  
  • Types of Oncology
  • Surgical Oncology
  • Cancer Biomarkers
  • Cancer Treatments and Therapy

Target audiences at World Summit on Oncology & Oncologists:

About City :

Brisbane, capital of Queensland, is a large city on the Brisbane River. Clustered in its South Bank cultural precinct are the Queensland Museum and Sciencentre, with noted interactive exhibitions. Another South Bank cultural institution is Queensland Gallery of Modern Art, among Australia's major contemporary art museums. Looming over the city is Mt. Coot-tha, site of Brisbane Botanic Gardens.

Brisbane is the third most populous city in Australia. Brisbane's metropolitan area has a population of over 2.5 million, and the South East Queensland metropolitan region, centred on Brisbane, encompasses a population of more than 3.6 million.

The Brisbane central business district stands on the historic European settlement and is situated inside a peninsula of the Brisbane River, about 15 kilometres (9 miles) from its mouth at Moreton Bay, a bay of the Coral Sea The metropolitan area extends in all directions along the hilly floodplain of the Brisbane River Valley between Moreton Bay and the Taylor and D'Aguilar mountain ranges. It sprawls across several of Australia's most populous local government areas (LGAs)—most centrally the City of Brisbane, which is by far the most populous LGA in the nation. The demonym of Brisbane is "Brisbanite", whilst common nicknames include "Brissy", "River City" and "Brisvegas".

Brisbane is a popular tourist destination, serving as a gateway to the state of Queensland, particularly to the Gold Coast and the Sunshine Coast, which are home to numerous popular surf beaches, located immediately south and north of Brisbane respectively. Major landmarks and attractions include South Bank Parklands and the Queensland Cultural Centre (including the Queensland Museum, Queensland Art Gallery and Gallery of Modern Art), City Hall, the Story Bridge, the City Botanic Gardens and Parliament of Queensland, the Howard Smith Wharves, Fortitude Valley (including James Street and Chinatown), West End, the Teneriffe woolstores precinct, Roma Street Parkland, New Farm Park (including the Brisbane Powerhouse), St John's Cathedral, the Lone Pine Koala Sanctuary, Mount Coot-tha Lookout and Botanic Gardens, the Taylor and D'Aguilar mountain ranges, the Brisbane River and floating Riverwalk, as well as Moreton Bay, its islands (including Moreton, North Stradbroke and Bribie islands), and coastal suburbs (including Shorncliffe and Wynnum and those on the Redcliffe Peninsula).

SESSIONS & TRACKS

Track 1Melanoma Of The Head And Neck

Melanoma is a danger of concealing passing on cells (melanocytes) found dominatingly in the skin yet in addition found in the eyes, ears, GI tract, leptomeninges, and oral and genital mucous films. The rehash of debilitating melanoma appears, all around, to connect at a rankling rate all through the world over the navigate of the last 30–40 years Most head and neck melanomas (70–90%) occur on the face , with the cheek the most generally observed site. Shallow spreading melanoma is dependably associated with a nevus and oftentimes occurs in increasingly energetic patients. Nodular melanomas are the going with most standard make. Lentigo maligna melanomas are depicted by a drawn out winding change sort out. They have a proclivity for the dermal-epidermal convergence point and will in general take after hair follicles. Acral lentiginous melanomas are usually organized on the palms or soles. Desmoplastic melanomas can be found in association with before melanocytic wounds and would more be able to an important bit of the time is amelanotic, making their insistence increasingly problematic. They tend to be depicted by outstanding metastasis with a higher neighborhood rehash rate, what's more increasingly unique per neural obligation.

Track  2 : Neuro-Oncology

A cerebrum tumor happens when unpredictable cells outline inside the brain. Unsafe or dangerous tumors and liberal tumors are the two crucial sorts of tumors. Cancer-causing tumors can be passed on into from fundamental tumorswhich starts inside the brain, and the helper tumors which are spread wherever else, recognized as cerebrum metastasis tumors. A wide scope of mind tumors may convey signs that complexity dependent upon the cerebrum part included. These symptoms may incorporate issue with vision, heaving, cerebral torments, seizures, and mental changes. The cerebral torment is particularly increasingly lamentable close to the start of the day and heads out with heaving. Progressively explicit issues may join inconvenience in walking, talking, and with sensation. As the ailment advances conspicuousness may occur.

Track 3 : Breast Cancer

Chest tumor begins in the cells of the chest. A frightful tumor is a get-together of advancement cells that can shape into and destroy close to tissue. It can in like way metastasize to different pieces of the body. Cells in the chest when in doubt change and never again make or act regularly. These developments may impel non-hazardous chest conditions, for example, atypical hyperplasia and wounds. They can in like way incite non-disease causing tumors, for example, intraductal papillomas.

  • Track 3-1 Abortion–breast cancer hypothesis
  • Track 3-2 Lobular carcinoma
  • Track 3-3 Breast reconstruction
  • Track 3-4 Breast cancer screening

Track 4 : Tonsil Cancer

Throat disorder infers malignant growth causing tumors that make in your throat (pharynx), voice box (larynx) or tonsils. Throat is a strong cylinder that starts behind your nose and finishes in your neck. Throat advancement reliably starts in the level cells that line inside your throat. Throat advancement can in like way sway the bit of ligament (epiglottis) that goes about as a best for your windpipe. Tonsil tumor, another kind of throat threat, impacts the tonsils, which are masterminded on the back of the throat. Throat Cancer Surgery is sensible methodology to treat the infection beneficially and moreover various methodologies are available.

Track 5 : Molecular Biology of Head and Neck Cancers

Head and Neck advancements comprise a veritable test for oncologists over the globe, with one individual passing on each hour of dependably. It can bend and deform the face, strip away the voice and keep one from guaranteeing his essential capacities to eat, drink and swallow. The psychosocial effect can be to a mind blowing degree squashing. Systems in nuclear remedy are generally used to treat the tumors. From starting at now being viewed as a homogenous substance, it is at present an all around obvious conviction that Head and Neck disease is fittingly called "Head and neck malignancies" in setting of their acquired and atomic heterogeneity in spite of sharing histological and etiological homogeneity

  • Track 5-1 Molecular basis of risk factors for the development of Head and Neck Cancer
  • Track 5-2 Molecular Pathogenesis of Oral cancer

Track 6 : Throat Cancer

Throat ailment infers malignancy causing tumors that make in your throat (pharynx), voice box (larynx) or tonsils. Throat is a strong cylinder that starts behind your nose and finishes in your neck. Throat improvement reliably starts in the level cells that line inside your throat. Throat improvement can in like way sway the bit of ligament (epiglottis) that goes about as a best for your windpipe. Tonsil tumor, another kind of throat peril, impacts the tonsils, which are masterminded on the back of the throat. Throat Cancer Surgery is sensible system to treat the ailment beneficially and moreover various techniques are available.

 . Track 6-1 Brachytherapy for throat cancer

·  Track 6-2 Squamous cell carcinoma

·  Track 6-3 Adenocarcinoma

·  Track 6-4 3D-conformal radiation therapy for throat cancer

·  Track 6-5 Intensity-modulated radiotherapy for throat cancer

Track 7 : Cancer Proteomics

Proteomics types of progress are utilized for early disclosure and finding of diseases for the difference in novel medicinal executives. Perceiving proof of biomarker what's more the assessment of protein articulation of the disease are broke down through proteomics stages. These assessments have incited the progress of finding new arrangements and focused on therapeutics towards the tumor cells. ID, doubt, finding and treatment of chest danger is straightforwardly conceivable with the kinds of progress in the field of proteomics near to the use of mass spectrometry. The revelation of the protein layouts has empowered specialists to see the contamination and infection free-state related with chest disease has been revealed with the difference in proteomics movements. This exposure prompts modified treatment for the patients. Proteins conferred or found in the serum, plasma and the tumor cells utilizing the novel systems give an unmatched perspective of the heterogeneity of the diseases.

  • Track 7-1 Leukemia and lymphoma
  • Track 7-2 Tumor biology
  • Track 7-3 Protein expression of cancer genes
  • Track 7-4Genes and protein altered in cancer

Track 8 : Cancer Stem Cells

Harm undifferentiated life forms, similar to each undeveloped cell, are unspecialised (for example they have no tissue-explicit structures), they can free and restore themselves for long broadens and they can offer rising to specific cells. They can thusly rehash tumor heterogeneity as they can be found in tumors. Research so far has proposed they in addition have multi remedy and radiotherapy security.

  • Track 8-1 Haematological Cancers
  • Track 8-2 Chemotherapies
  • Track 8-3 Metastatic Disease
  • Track 8-4 Stem Cells

Track 9 : Types Of Cancers

Developments are described and named depending on the kind of cell they started and have particular structures. A couple of cases are according to the accompanying:

Pancreatic Cancer

Cerebrum Tumors

Skin Cancer

Retinoblastoma

Conceptive framework related Cancers

Bosom Cancer

Blood Cancer

  • Track 9-1 Pancreatic Cancer
  • Track 9-2 Brain Tumors
  • Track 9-3 Skin Cancer
  • Track 9-4 Retinoblastoma
  • Track 9-5 Reproductive system related Cancers
  • Track 9-6 Breast Cancer
  • Track 9-7 Blood Cancer

Track 10 :  Oncology and Radiology

A radiation oncologist is a specialist who uses ionizing radiation, (for instance, megavoltage X-shafts or radionuclides) in the treatment of development. Radiation oncology is one of the three basic qualities, the other two being surgical and therapeutic oncology, drew in with the treatment of tumor. Radiation can be given as a remedial strategy, either alone or in blend with surgery and in addition chemotherapy. It may moreover be used palliative, to reduce reactions in patients with sad malignancies. A radiation oncologist may similarly use radiation to treat some ideal diseases, including kind tumors. Radiation oncologists work personally with various specialists, for instance, surgical oncologists, interventional radiologists, inside medication subspecialists, and therapeutic oncologists, and furthermore remedial physicists and specialists as a noteworthy part of the multi-disciplinary ailment gathering.

  • Track 10-1 Germ cell tumors
  • Track 10-2 Radiation oncology
  • Track 10-3 Medical oncology
  • Track 10-4 Surgical oncology
  • Track 10-5 Carcinoma
  • Track 10-6 Cell growth

Track 11 : Cancer Pharmacology

Development pharmacology unite assessments of the significant instrument of banner transduction related with cell growth and apoptosis, the arrangement of activity of antagonistic to neoplastic specialists, the outline and exposure of new arrangements, crucial sections of DNA fix and DNA hurt adaptability and the progress of novel strategies for quality treatment.

  • Track 11-1 Human cancer cell lines
  • Track 11-2 Genetic manipulation of cancer
  • Track 11-3 Malignant transformation
  • Track 11-4 Cancer cell proliferation

Track 12 : Factors Associated with Cancer Prevalence

Smoking behavior as pointers in the model. This data isn't open in the MEPS for the prior years. We differentiated the eventual outcomes of our model and without these components and assumed that they didn't puzzle the connection between harm The connection between tumor inescapability and race, compensation, assurance, and guidance was evaluated using the Medical Expenditure Panel Survey data from 1996-2007. The target of this examination was to give some comprehension into how assortments in race and budgetary segments sway the inescapability of tumor. This examination was driven for any development and for the four most ordinary tumor goals i.e lung, colorectal, chest and prostate. From the outset, the model was evaluated using MEPS data from 2002-2007 to fuse weight record, exercise and inescapability and race, pay, assurance, and preparing. Along these lines, we dropped these variables from the assessment and could develop our data to join the years 1996-2001. This extended the amount of individuals with tumor in our examination and was basic for our assessment of the four most standard sickness goals.

  • Track 12-1 Cancer-Causing Substances
  • Track 12-2 Chronic Inflammation
  • Track 12-3 Immunosuppression

Track 13 : Nanotechnology in Cancer Treatment

The usage of nanotechnology being developed treatment offers some invigorating potential outcomes, including the likelihood of obliterating peril tumors with irrelevant harm to sound tissue and organs, and furthermore the disclosure and move of disease cells before they layout tumors. One treatment being worn down consolidates focused on chemotherapy that passes on a tumor-executing master called tumor rot factor alpha (TNF) to advancement tumors. TNF is related with a gold nanoparticle close by Thiol-derivatized polyethylene glycol (PEG-THIOL), which covers the TNF bearing nanoparticle from the sheltered framework. This permits the nanoparticle to course through the circulatory system without being trapped.

Track 14 : Novel Approaches and Pharmaceutical Drugs for Cancer Treatment

There are fundamentally 2 procedures used for limited vehicle of anticancer Treatment. To begin with, the dermal pharmaceutical vehicle and second is the subcutaneous and intra-tumoral relationship of hydrogel. Restricted drug transport is an approach to manage pass on the solution from a measurements edge to a specific site in the normal framework, where its whole pharmacological impact is required. Close by association of chemotherapeutic administrators at the tumor site is likewise thought to improve the chemo-responsiveness by uncovering tumors and neighboring metastases to high medication fixation while diminishing its central presentation.

  • Track 14-1 Nanotechnology
  • Track 14-2 Anti-cancer Drugs
  • Track 14-3 Active targeted drug delivery
  • Track 14-4 Passive targeted drug delivery
  • Track 14-5 Micelles and dendrimers
  • Track 14-6 Artificial DNA nano structures

Track 15 : Nursing oncology

There are various types of specialist care related with development prescriptions. Master helpful escorts, Ward remedial gatekeepers, Community therapeutic managers, Specialist palliative consideration helpful orderlies, Marie Curie Cancer Care Nurses. Master orderlies work basically in authority's workplaces; regardless, some give mind in the patient's home. They may have some dominance in a particular damage for instance chest, lung, head and neck disease, or a specific treatment, for instance chemotherapy. Gathering escorts give an expansive grouping of nursing care including helping patients when they leave office, taking out appends, clearing wounds and giving out some arrangement at home. Expert palliative consideration remedial watchmen have bent in directing torment and differing appearances and can offer help for individuals with improvement and their families.

The pushed Oncology Nurse is master's readied help with learning and most remote point in a degree of hazard nursing. Every single helpful controller moves along a path from understudies to star. It is seen that, paying little regard to paying little character to the likelihood that a generalist, explicit oncology or pushed Oncology Nurse, each individual therapeutic escort will association therefore from disciples to master.

  • Track 15-1 Anticipatory Grieving
  • Track 15-2 Altered Nutrition
  • Track 15-3 Fluid Volume
  • Track 15-4 Risk for Infection

Track 16 : Organ-Defined Cancers

Growth can happen anyplace in the body. The most well-known locales of malignancy among men incorporate lung, prostate, colon, rectum, stomach and liver. Also, those for among ladies are bosom, colon, rectum, lung, cervix and Stomach Cancers . Malignancies are frequently portrayed by the body part that they started in. Notwithstanding, some of the body parts contain various kinds of tissues, diseases can also be arranged by the sort of cell that the tumor cells started from. The kind of malignancy a man should have been referred to legitimately as various sorts of tumor can carry on diversely and react to various medicines.

  • Track 16-1 Ovarian cancer treatment 
  • Track 16-2 Pancreatic cancer treatment
  • Track 16-3 Radiation treatment
  • Track 16-4 Skin cancer treatment
  • Track 16-5 Colon cancer treatment

Track 17 : Types of Oncology

Oncology is a part of drug that courses of action with the repugnance, finding, and treatment of development. Unmistakable tumors impacting assorted pieces of the body for example blood malignant growth, prostate, lungs, platelets (leukemia) or various organs carry on in different path are of different assessments and cell compose, respond always to treatment and have assorted game plan of convincing treatment routine. An oncologist is an expert who treats ailment. Inside oncology there are a couple of sub-distinguishing strengths that game plan with different sorts of ailment and blood development makes or blood malignant growth types.

Track 18 : Surgical Oncology

Therapeutic method is used to examine stage and treat development, and certain harm related symptoms. It is the part of therapeutic method associated with oncology; it revolves around the organization of tumors, especially cancer-causing tumors. Careful oncology is a specific district of oncology that attracts masters in the fix and organization of tumor. Despite whether a patient is a likelihood for restorative technique depends upon factors, for instance, the sort, gauge, region, audit and period of the tumor, and also broad prosperity parts, for instance, age, physical health and other helpful wares. For certain patients, medicinal technique will be gotten together with other development drugs, for instance, chemotherapy, radiation treatment or hormone treatment.

Track 19 : Cancer Biomarkers

A malady biomarker alludes to a substance or procedure that is normal for the proximity of danger in the body. A biomarker may be a molecule discharged by a tumor or a specific response of the body to the closeness of harm. Inherited, epigenetic, proteomic, glycemic, and imaging biomarkers can be used for malady assurance, surmise, and the investigation of infection transmission. While some danger biomarkers can be used to predict how commandingly your tumor will create, and are along these lines important for looking over your representation, the most reassuring usage of biomarkers today is to perceive which medicines a patient's development could possibly respond to.

  • Track 19-1 Imaging biomarkers
  • Track 19-2 Clinical biomarkers
  • Track 19-3 Genetic biomarkers
  • Track 19-4 Predictive cancer biomarkers
  • Track 19-5 Molecular biomarkers
  • Track 19-6 Cell free biomarkers

Track 20: Cancer Treatments and Therapy

Disease can be treated with by different methods. The choice of treatment depends on the region and grade of the tumor and the period of the infection, and also the general state of the patient). Various test harm drugs are similarly being chipped away at. A couple of individuals with tumor will have only a solitary treatment. In any case, most by far have a mix of prescriptions, for instance, therapeutic system with chemotherapy just as radiation treatment. You may similarly have immunotherapy or coordinated treatment.

MARKET ANALYSIS

Market Analysis:

Cancer is a disease characterized by uncontrolled cell proliferation. There are more than 100 types of cancer. The most widely recognized reasons for disease passing are malignant growths of Lung (1.69 million deaths), liver (788 000 deaths), Colorectal (774 000 deaths), Stomach (754 000 deaths) and Breast (571 000 deaths) which accounts for nearly half of new cases per year. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

The kinds of cancer we expect to increase the most are:

Melanoma (the deadliest kind of skin cancer) in white men and women.

Prostate, kidney, liver, and bladder cancers in men.

Lung, breast, uterine, and thyroid cancers in women.

Cancer is among the leading causes of death worldwide. In 2012, there were 14.1 million new cases and 8.2 million cancer-related deaths worldwide. The number of new cancer cases per year is expected to rise to 23.6 million by 2030. The most recent SEER Cancer Statistics Review, released in April 2019, shows that cancer death rates decreased by 1.8% per year among men from 2006 to 2015, 1.4% per year among women from 2006 to 2015 and 1.4% per year among children ages 0–19 from 2011 to 2015.

Global Oncology/Cancer drugs Market is expected to garner $111,938.4 million by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for cancer treatment with the identification of tumour cell specific genes. The number of approved cancer therapies continues to rise. The continued rise and impact of immune-oncology has been largely centred on the PD-1 and PD-L1 checkpoint inhibitors, which have broad efficacy across solid tumours and are used across 23 different tumour types. Overall, the global market for oncology therapeutic medicines will reach as much as $200 billion by 2022, averaging 10—13% growth over the next five years, with the U.S. market reaching as much as $100 billion by 2022, averaging 12–15% growth.

In 2019, the global cancer therapy market was valued at USD 136,254.35 million, and is estimated to be valued at USD 220,701.26 million in 2024, witnessing a CAGR of 8.37%. Factors that are driving the market growth include

  • Increased Patient Assistance Programs (PAPs)
  • Increased government initiatives for cancer awareness
  • Rising prevalence of cancer worldwide
  • Strong R&D initiatives from major research in Cancer

Target Therapy Segment is expected to show the Fastest Growth in the Forecast Period

The target therapy segment is expected to show the highest CAGR of 9.68% during the forecast period. The target therapy basically includes hormone therapies, angiogenesis 

Inhibitors, immunotherapies, signal transduction inhibitors, gene expression modulators, apoptosis inducers, and toxin delivery molecules. Targeted therapy is getting great importance due to its high specificity toward cancerous cells, while eliminating the toxicity to off-target cells.

The Blood cancer segment is believed to account for the largest market size over the forecast period. This is majorly attributed to the higher and continuously increasing prevalence of breast cancer across the world. Over 2,66,120 new cases of invasive blood cancer are expected to be diagnosed in men, women, small children in the US, as per estimated by the Blood  Cancer Organizations in 2019 along with 63,960 new cases of non-invasive (in situ) blood cancer.

North America currently dominates the market for cancer therapy. This region is expected to increase its market share in the future, owing to the increased adoption of cancer therapy. The United States holds majority of the market in the North American region, due to the rising prevalence of cancer in the country. In 2016, 1.6 million people suffered from cancer, and around 0.5 million people died from cancer, as reported by the National Cancer Institute (NCI). This figure indicates that the prevalence of cancer is rapidly increasing in the United States.

LEARN MORE

European Cancer Universities

ESO - European School of Oncology | Kharkiv National Medical University | Medical University – Plovdiv | Medical University – Pleven | Bukovinian State Medical University | KU Leuven – University of Leuven, Belgium | Cancer Science Conferences | Technical University of Munich | Humboldt University of Berlin | University of Amsterdam | Erasmus University Rotterdam | Leiden University | RWTH Aachen University | University of Groningen | Utrecht University | University of Tübingen | Yerevan State Medical University | University of Copenhagen | Oncology Conferences | Maastricht University | Medical University of Vienna | University of Milan | University of Barcelona

USA Cancer Universities

Stanford University | Johns Hopkins School of Medicine | UCSF School of Medicine | Duke University | Yale School of Medicine | Harvard Medical School | UNC School of Medicine | Cancer Conferences | UT Southwestern Medical School | The University of Chicago Pritzker School of Medicine | Maryland School of Medicine | University of Cincinnati Academic Health Center | University of Wisconsin School of Medicine | University of Minnesota Medical School | Stony Brook School of Medicine | Vermont College of Medicine | Wayne State School of Medicine | Emory University: School of Medicine | Cancer Science Conferences | University of Utah School of Medicine | Vanderbilt University | Penn State Hershey College of Medicine | Alabama School of Medicine | UMASS School of Medicine | Rutgers New Jersey Medical School | Oklahoma College of Medicine

Asian Cancer Universities

University of Tokyo | National University of Singapore | Oncology Conferences | Kyoto University | University of Hong Kong | Peking University | Seoul University | National Taiwan University | Osaka University | Tsinghua University | Duke-NUS Medical School | Asian Medical Institute | International Medical University | Taipei Medical University | Allianze University College of Medical Sciences | Mahidol University | Herat University Faculty of Medicine | Cancer Conferences | Karaganda State Medical University | Perdana University Graduate School of Medicine | Chongjin Medical University | Nanyang Technological University

African Cancer Universities

Makerere University | Cancer Science Conferences | University of Ghana At Legon | University of Nairobi | University of Ibadan | University of Botswana | University of Lagos | Cheikh Anta Diop University  | University of Dar Es Salaam | University of Cape Town | Stellenbosch University | University of Pretoria| Cairo University | University of Witwatersand | University of Kwazulu-Natal | University of Western Cape | Oncology Conferences| Mansoura University | University of Johanessburg | Orotta School of Medicine | Addis Ababa University | Aga Khan University Medical School | Egerton University Medical School | University of Malawi College of Medicine | Ambrose Alli University | Walter Sisulu University | Busitema University School of Medicine

Worldwide Cancer Hospitals

Cancer Hospitals in Europe

Chiro Hospital Group, Spain | Cyberknife Center Hamburg, Germany | Cancer Conferences | Vithas Xanit International Hospital, Spain | Anadolu Medical Center, Turkey | Hygeia Hospital, Greece | Neolife Oncology Center, Turkey | Medipol Mega University Hospital, Turkey  | Teknon Medical Center, Spain | Ruber International Hospital, Spain | British Hospital Lisbon XXI, Portugal | Clinic of L'Alma, France | Clinic Hirslanden & Klinik Im Park, Switzerland | Sanitas Hospitals, Spain | Sant Joan de Déu-Barcelona Children's Hospital, Spain | HM Hospitals, Spain | Koc University Hospital, Turkey | University Hospital HM Montepríncipe, Spain | Medicana Healthcare Group  Turkey| Cancer Science Conferences | University Hospital HM Sanchinarro, Spain | Heidelberg University Hospital, Germany | Hisar Intercontinental Hospital, Turkey | Klinikum Stuttgart, Germany | Nisa Pardo de Aravaca Hospital, Spain | Liv Hospital, Turkey | Hospital Quirón Valencia, Spain

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Talk to Us

Speak directly to one of our conference representatives by calling.


+0044-2033180199

Mail Us

E-mail us your questions about the conference. We will respond to your questions.


contact@euroscicon.com

Contact Us

Have questions?
We'll be in touch within 24 hours.


Contact Us

Address

EuroSciCon Ltd
35 Ruddlesway,
Windsor, Berkshire,
SL4 5SF, UK

EuroSciCon Events are produced by Euroscicon Ltd

EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International will issue Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.